A leading company in the creation, development and manufacturing of patient-centered healthcare solutions, Berry Global Group, Inc., has made investments in new resources and manufacturing skills to boost its capacity for producing healthcare products by up to 30% at three of its locations in Europe.
In Bangalore, Berry opened a manufacturing facility and a healthcare center of excellence. The latest investments, according to Berry, demonstrate the company’s dedication to providing high-quality packaging and drug delivery devices that improve patient experience by improving medication administration and adherence.
“As pharmaceutical innovations progress, so should the packaging and support that delivers each dose. Berry Global is here to provide that expertise in the creation of patient-centered packages and drug delivery device design. We continue to invest in the latest healthcare technologies to help our customers offer patients a safe and improved experience with every dose,” said Walid Hamza, EVP Global Healthcare at Berry Global.
The company’s officials claim that Berry’s locations in Osnago, Italy and Offranville, France, which are close to hubs for pharmaceutical manufacture and filling, contribute to their ability to provide localized services and quick response times.
The production of ‘best-in-class’ standard and custom pharmaceutical packaging and drug administration devices, including ophthalmic and nasal items like the Rispharm multi-dose eye dropper, is the specialty of Berry’s Offranville location. In order to fulfil the increasing market demand, particularly for Berry’s competence as a contract development and manufacturing organization (CDMO), significant investments have been made at the site, including additional cleanroom production to ISO7 level.
The Osnago site of Berry, which produces throat spray actuators and the Sirone site, which produces accompanying bottles, will see investments to meet the growing demand for oral solutions, both prescription and over-the-counter, for the prevention and treatment of respiratory diseases and infections brought on by elevated air pollution.
For more details : https://euroinsightscare.com/
